JonesTrading Initiates Coverage On Cullinan Oncology with Buy Rating, Announces Price Target of $22
Portfolio Pulse from Benzinga Newsdesk
JonesTrading analyst Soumit Roy has initiated coverage on Cullinan Oncology (NASDAQ:CGEM) with a Buy rating and a price target of $22.
October 06, 2023 | 9:50 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cullinan Oncology has been initiated with a Buy rating by JonesTrading, with a price target of $22.
The initiation of coverage by JonesTrading with a Buy rating and a price target of $22 indicates a positive outlook for Cullinan Oncology. This could potentially attract investors, driving up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100